![Overview of clinical trials for dry age-related macular degeneration Cheng WS, Lu DW, Chiang CH, Chang CJ - J Med Sci Overview of clinical trials for dry age-related macular degeneration Cheng WS, Lu DW, Chiang CH, Chang CJ - J Med Sci](https://www.jmedscindmc.com/articles/2017/37/4/images/JMedSci_2017_37_4_121_213578_t8.jpg)
Overview of clinical trials for dry age-related macular degeneration Cheng WS, Lu DW, Chiang CH, Chang CJ - J Med Sci
Age-Related Macular Degeneration Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration.
![NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace dying cells in retina | National Institutes of Health (NIH) NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace dying cells in retina | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/news-events/news-releases/2019/20191216-iPSC.jpg)
NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace dying cells in retina | National Institutes of Health (NIH)
![Significant Number Of Drugs Will Launch For The Treatment Of Age-Related Macular Degeneration By 2026 Says GlobalData Significant Number Of Drugs Will Launch For The Treatment Of Age-Related Macular Degeneration By 2026 Says GlobalData](https://vertassets.blob.core.windows.net/image/dac25e73/dac25e73-b6ca-404e-9ace-b205ca5671a2/vcsprasset_3434416_93750_c0bd42d7_8b52_4fbf_baaa_9ea8a6f5baea_0.png)
Significant Number Of Drugs Will Launch For The Treatment Of Age-Related Macular Degeneration By 2026 Says GlobalData
![An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma | Eye An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma | Eye](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41433-021-01766-w/MediaObjects/41433_2021_1766_Fig1_HTML.png)
An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma | Eye
![Exudative (Wet) Age-Related Macular Degeneration (AMD): Practice Essentials, Background, Pathophysiology Exudative (Wet) Age-Related Macular Degeneration (AMD): Practice Essentials, Background, Pathophysiology](https://img.medscapestatic.com/pi/meds/ckb/43/31143tn.jpg)
Exudative (Wet) Age-Related Macular Degeneration (AMD): Practice Essentials, Background, Pathophysiology
![IJMS | Free Full-Text | Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules IJMS | Free Full-Text | Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules](https://pub.mdpi-res.com/ijms/ijms-20-01693/article_deploy/html/images/ijms-20-01693-ag.png?1571332852)
IJMS | Free Full-Text | Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules
![Unsuccessful Trials That Investigated Therapies for Age-Related Macular Degeneration | Ophthalmic Surgery, Lasers and Imaging Retina Unsuccessful Trials That Investigated Therapies for Age-Related Macular Degeneration | Ophthalmic Surgery, Lasers and Imaging Retina](https://journals.healio.com/cms/asset/953d5fa0-bf7e-49c2-b754-f353b5ec7d91/10.3928_23258160-20201104-01-table1.jpg)
Unsuccessful Trials That Investigated Therapies for Age-Related Macular Degeneration | Ophthalmic Surgery, Lasers and Imaging Retina
![IJMS | Free Full-Text | Exudative versus Nonexudative Age-Related Macular Degeneration: Physiopathology and Treatment Options IJMS | Free Full-Text | Exudative versus Nonexudative Age-Related Macular Degeneration: Physiopathology and Treatment Options](https://www.mdpi.com/ijms/ijms-23-02592/article_deploy/html/images/ijms-23-02592-g001.png)
IJMS | Free Full-Text | Exudative versus Nonexudative Age-Related Macular Degeneration: Physiopathology and Treatment Options
![Endpoints selection in registration clinical trials and the needs of real-world clinical practice with the example of anti-VEGF therapy in neovascular age-related macular degeneration - Astakhov - Ophthalmology Reports Endpoints selection in registration clinical trials and the needs of real-world clinical practice with the example of anti-VEGF therapy in neovascular age-related macular degeneration - Astakhov - Ophthalmology Reports](https://journals.eco-vector.com/public/journals/2/cover_issue_3488_en_US.jpg)
Endpoints selection in registration clinical trials and the needs of real-world clinical practice with the example of anti-VEGF therapy in neovascular age-related macular degeneration - Astakhov - Ophthalmology Reports
![Emerging Pharmacological Targets for Treatment of Dry Age-related Macular Degeneration and Geographical Atrophy Emerging Pharmacological Targets for Treatment of Dry Age-related Macular Degeneration and Geographical Atrophy](https://publinestorage.blob.core.windows.net/e96b90b0-6e2c-4099-acd3-de9beaa4255c/jerp-22-66-g002.jpg)
Emerging Pharmacological Targets for Treatment of Dry Age-related Macular Degeneration and Geographical Atrophy
![A Clinical and Preclinical Assessment of Clinical Trials for Dry Age-Related Macular Degeneration - Ophthalmology Science A Clinical and Preclinical Assessment of Clinical Trials for Dry Age-Related Macular Degeneration - Ophthalmology Science](https://www.ophthalmologyscience.org/cms/asset/36de532b-1413-4dec-947d-8ab464f05527/gr1.jpg)